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ABSTRACT 
Background 
Intermittent Preventive Therapy using sulfadoxine pyrimethamine (IPTp-SP) is a malaria control 
strategy to reduce cases of malaria in malaria endemic countries. However, the administration of 
the recommended three doses of IPTp throughout the stages of pregnancy still remains low in 
Nigeria even though, Nigeria is a malaria endemic country. Quality improvement approach has 
been demonstrated to improve practice among healthcare providers. This study therefore used a 
quality improvement approach to train and coach healthcare providers in order to improve the 
administration of the recommended doses of IPTp to pregnant women receiving antenatal care 
(ANC) services.    
Methods 
A quasi-experimental study design was carried out to evaluate the effect of quality improvement 
approach consisting of training and coaching of healthcare providers to improve the administration 
of IPTp during ANC service. Primary Healthcare Centre (PHC) Samaru was purposively selected 
and twelve healthcare providers participated in the study. ANC daily register was reviewed pre-
intervention, intervention and post-intervention period of the study. Data were analysed using line 
graphs and run charts. 
Results 
A total of 36 ANC visit weeks were observed between 21st November 2016 and 27th July 2017. 
The mean level for IPTp1 administration pre-intervention was 105.85% (SD: 29.28) and 75.20% 
(SD: 16.89) for IPTp2+. The levels of IPTp1 administration were relatively stable from Week 1 to 
Week 10 although, there was overestimation of IPTp1 as 8 of the 16 Weeks in the pre-intervention 
period i.e. Weeks 3, 5, 7, 8, 11, 13, 15 and 16 all had more than 100% of eligible women 
administered IPTp1. The patterns of IPTp2+ administrations shows the levels of IPTp2+ 
administration were erratic. There was evidence indicating the process of IPTp1 was relatively 
stable post-intervention as the data crosses the median line only six times i.e. 7 runs. This indicates 
that the process of IPTp1 was within normal variation over the post-intervention period.  There 
was an upward shift showing immediate improvement of the administration of IPTp2+ post-
intervention although, there was a non-random variation in the administration of IPTp2+. The 
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improvements of IPTp were not sustainable due to stock-outs. The quality of the ANC daily 
register was poor. 
Conclusion 
The integrated training and coaching intervention approach improved the administration of the 
recommended three doses of IPTp within the context of a PHC. These findings should be 
interpreted with caution as the impact of the intervention may not have reached its full impact due 
to the short post-intervention assessment.  Stock-outs remains a huge barrier to the administration 
of IPTp under DOT during ANC services. The data quality of the ANC daily register improved 
post-intervention however, there were still slight errors thus, indicating that healthcare providers 
need constant coaching. It is important to integrate training and coaching of healthcare providers 
in order to have desired and sustained outcomes. 
Keywords: Malaria in pregnancy, IPTp, IPTp-SP, SP, ANC, Pregnant women, Healthcare 
providers, administration, QI, integrated training and coaching. 
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DEFINITION OF TERMS 
Coaching: This is the supervision, monitoring, follow-up meetings and putting up posters at the 
clinic within the context of this study. 
Direct Observed Therapy (DOT): Taking medication under the supervision/ observation of a 
healthcare provider. 
Healthcare providers: This includes nurses, auxiliary nurses, midwives and community 
healthcare workers (CHWs: These cadre of healthcare providers work in the clinic even though 
ideally they are supposed to be in the community providing healthcare services) who are directly 
involved in providing ANC services within the context of this study. 
Implementation strategy: This involves the intervention methods used in this study 
Integrated approach to training: This involves training and coaching of healthcare providers 
within the context of this study. 
Intermittent Preventive Therapy using sulfadoxine pyrimethamine (IPTp-SP): It is a full 
therapeutic course of anti-malaria medicine administered to pregnant women during routine ANC 
visit, regardless of  whether the women is infected with malaria or  not (WHO, 2014b). It is 
otherwise known as IPTp. 
Intermittent Preventive Therapy (IPTp1): This is the first dose of therapeutic course of 
antimalarial medicine administered to pregnant women (WHO, 2014b). 
Intermittent Preventive Therapy (IPTp2):  This is the second dose of therapeutic course of 
antimalarial medicine administered to pregnant women (WHO, 2014b) 
IPTp 2+: This is the combination of IPTp2 and IPTp3 (Exavery et al., 2014). 
Pills: Refers to the three tablets of IPTp-SP administered per dosage within the context of this 
study. 
Quality Improvement:  This is an effective, proven way to improve care for patients, clients and 
residents as well as improve practice for healthcare staff. Also, quality improvement consists of 
systematic and continuous action that leads to measurable improvements in the health status of 
target population and health services (US Department of Health and Services, 2011). 
xii 
 
Run Chart: This is a measure of a line graph plotted over time with the median showing as the 
horizontal line in order to identify improvement or degradation in a process (Anhøj and Olesen, 
2014). 
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CHAPTER 1: INTRODUCTION 
 
1.0 INTRODUCTION OF CHAPTER 
This chapter discusses the background information of the research project, literature review on the 
topic and a rationale to support why the study was conducted. It further explores the research 
problem, study aim, research question and objectives of the study. 
1.1 Background 
Worldwide, maternal health has continued to be a global public health issue that has received so 
much attention, yet maternal mortality indices are unacceptably high especially in sub-Saharan 
Africa (WHO, UNICEF, UNFPA, 2015). Studies have shown that one of the leading causes of 
maternal morbidity and mortality is malaria and more than half of the world population live in 
malaria endemic areas (Diala et al., 2013; WHO, 2014a). The Nigeria Demographic and Health 
Survey (NDHS) reported that each year approximately 7.5 million pregnant women developed 
malaria (NPC and ICF 2009).  Nigeria a sub-Saharan country, has one of the highest maternal 
mortality ratio of approximately 814/100 000 live births (WHO, UNICEF, UNFPA, 2015). 
Malaria in Pregnancy (MIP) is one of the leading causes of maternal deaths accounting for about 
11% of maternal mortality in Nigeria (USAID 2013). Due to malaria being endemic in Nigeria, all 
pregnant women have the risk of developing the disease (Sanyaolu et al., 2013). In addition, reports 
show that about $36 211 760 million lost annually to malaria which has an impact on the economic 
growth and burden of disease in the country (NPC and ICF 2014). Thus, malaria is a significant 
threat to the country in achieving good health and well-being in relation to Sustainable 
Development Goal (SDG) three (Oleribe and Taylor-Robinson 2016). 
As a strategy for MIP prevention, the Nigerian government adopted the World Health Organization 
recommended guideline on Intermittent Preventive Therapy (IPTp) using Sulfadoxine 
Pyrimethamine (SP) (NPC and ICF 2009). In accordance with the WHO guidelines, it was 
recommended that IPTp-SP should be administered to all pregnant women at each scheduled ANC 
visits beginning from the second trimester until time of delivery, provided the doses were given 
one month apart (WHO 2014). Further, IPTp-SP should be administered as Directly Observed 
Therapy (DOT) of three tablets of Sulfadoxine/Pyrimethamine (500 mg/25 mg) monthly with a 
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minimum of three doses throughout antenatal period (WHO 2014). However, the NDHS (2013) 
showed that overall, only 49% of pregnant women took at least one dose of IPTp-SP while only 
15% took two or more doses of IPTp-SP, suggests a high attrition rate from IPTp1 (first dose) to 
IPTp2 (second dose) (NPC and ICF 2014). Additionally, the uptake of IPTp-SP remains low across 
the country with marginal increase of 13.8% in 2010 from 6.5% in 2008 (NPC and ICF 2014).  A 
study conducted by Fawole and Onyeaso (2008) showed that healthcare providers in primary 
healthcare clinics had limited knowledge about malaria prevention in pregnancy as only 13.9% 
had adequate knowledge on WHO strategy on IPTp. As a result contributing to the barriers of IPTp 
administration.   
1.2 Problem Statement 
Malaria in pregnancy continues to be a major public health burden in Nigeria that results in poor 
maternal health and adverse birth outcomes (Oyefabi, Sambo and Sabitu, 2015). The adoption and 
implementation of IPTp-SP strategy since 2005 by the Nigerian government for prevention of 
malaria in pregnancy has had little impact on the reduction of malaria prevalence in pregnancy 
(Agomo et al., 2009). Although, the World Health Organisation considered IPTp-SP to be effective 
when two or more doses are administered to pregnant women under directly observed therapy 
during ANC services, only 13% of pregnant women in Nigeria took at least two doses of IPTp-SP 
(USAID, 2015) and the uptake was lowest in northwestern Nigeria with only 3.9% of pregnant 
women receiving at least two doses of SP in IPTp as compared to 14% and 17% in south-west and 
south-east, respectively (NPC and ICF 2009).  Kaduna state, in north-west Nigeria, has one of the 
highest maternal mortality ratios in the country at 1012/ 100 000 live births. This doubles that of 
the national average and 25% more than the north-west region average (Kaduna State Ministry of 
Health, 2010).  Studies conducted in Sabon-Gari and Giwa Local Government Areas (LGAs) of 
Kaduna State, Nigeria showed that healthcare workers had misunderstanding on the recommended 
doses/administration schedule of IPTp leading to low compliance to guidelines which contributed 
significantly to poor coverage of IPTp in the LGAs (Katsayal et al., 2014a; Oyefabi, Sambo and 
Sabitu, 2015). Reports also showed that only 3% of the primary healthcare workers in Sabon-Gari 
LGA had adequate training on focused ANC of which IPTp was delivered routinely (NPHCDA, 
2016). Additionally, the administration of IPTp to pregnant women is low in Sabon-Gari LGA as 
only about 8% of pregnant women receive the second dose of IPTp-SP during ANC services in 
this setting (NPHCDA, 2016) . 
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1.3 Justification 
Malaria in pregnancy has a negative impact on the health of the mother and child as it contributes 
to low birth weight, miscarriage, maternal anaemia and it is one of the leading causes of neonatal 
and maternal deaths in Nigeria (Amoran, Ariba and Iyaniwura, 2012). The IPTp policy was 
adopted to prevent malaria in pregnancy as all pregnant women are at risk of developing malaria 
in Nigeria (Oyefabi, Sambo and Sabitu, 2015). However, the administration of IPTp has been 
generally low within the context of Sabon-Gari Local Government Area (LGA), Kaduna State, 
Nigeria (Oyefabi, Sambo and Sabitu, 2015). Healthcare providers play a crucial role in the 
administration of IPTp. However, studies have shown that they had limited knowledge on the 
administration of the recommended doses of IPTp to pregnant women receiving ANC services 
(Arulogun and Okereke 2012; Katsayal et al. 2015). Although, a study by Oyefabi et al. (2015)  
conducted training to healthcare providers on IPTp policy in Sabon-Gari PHCs, it was focused on 
creating awareness of IPTp to pregnant women. Thus, the effect of the training on IPTp-SP 
administration among healthcare providers in Sabon-Gari LGA remains unclear (Oyefabi, Sambo 
and Sabitu, 2015).  Furthermore, studies have shown that training alone in clinical settings is not 
always sufficient in changing healthcare providers’ behaviour in implementing evidenced-based 
interventions (Garces et al., 2010; Ramaswamy et al., 2015). Rather, successful performance of 
service delivery first needs an implementation team in order to contextualize intervention into local 
settings, then training followed-up with coaching (Ramaswamy et al., 2015). The 2015 study by 
Oyefabi, Sambo and Sabitu (2015) that showed low knowledge on IPTp among healthcare 
providers in Sabon-Gari LGA, indicate a need for training of healthcare providers in the setting to 
improve IPTp administration to pregnant women during ANC services. Additionally, Wandersman 
et al. (2015) indicated that the use of quality improvement (QI) is an effective way to improve care 
for patients and improve practice among healthcare providers. Thus, this study uses a QI approach 
to train and coach healthcare providers (integrated approach to training) on the administration of 
IPTp in a primary healthcare centre in Sabon-Gari LGA of Kaduna State, Nigeria. This study has 
the potential to improve the administration of IPTp during ANC services which is expected to 
contribute to reduction in maternal morbidity and mortality attributable to malaria.  
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1.4 Research Question, Aim and Objective 
 
1.4.1 Research question  
To what extent will an integrated approach to training improve the administration of IPTp 
by primary healthcare providers at PHC Samaru in Sabon-Gari LGA, Kaduna state, 
Nigeria? 
1.4.2 Aim  
To improve IPTp administration through training and coaching of healthcare providers at 
PHC Samaru in Sabon-Gari LGA, Kaduna State. 
1.4.3 Specific Objectives 
1. To determine the pre-intervention level of IPTp administration by healthcare providers 
at PHC Samaru. 
2. To conduct an integrated training and coaching intervention aimed at improving the 
administration of IPTp among healthcare providers at PHC Samaru. 
3. To measure the effect of the integrated training and coaching intervention on IPTp 
administration at PHC Samaru.  
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1.5 Literature Review 
1.5.1 Malaria in pregnancy (MIP): Issues in the administration of the recommended IPTp-
SP doses 
Malaria in pregnancy remains a major cause of adverse pregnancy outcomes and maternal deaths 
in Nigeria, a country with world’s largest population at risk of developing malaria (Diala et al., 
2013).  Similarly, pregnant women living in places with high prevalence of malaria were four 
times more likely have malaria and two times more likely to die of malaria than other adults (Gies 
et al., 2009). Furthermore, malaria accounts for 11% of all maternal mortality in Nigeria (Dawaki 
et al., 2016). It has been well established that various factors affect the effective administration of 
SP in IPTp all of which varies in duration of malaria transmission, intensity and seasonality 
(National Population Commission (Nigeria), National Malaria Control Programme (Nigeria) and 
MEASURE DHS/ICF International, 2012). In an attempt to reduce the high prevalence of malaria 
in pregnancy, the IPTp-SP strategy for malaria in pregnancy was adopted in Nigeria and many 
other sub-Saharan countries. However, studies have shown that the uptake is generally low in sub-
Saharan Africa (Oyefabi, Sambo and Sabitu, 2015; Yoder et al., 2015; Hill et al., 2016).  
1.5.2 Level of IPTp administration 
A study conducted in Sekondi-Takoradi region of Ghana showed that despite high awareness of 
IPTp-SP only 57.8% of pregnant women had received their first dose of IPTp-SP while 42.2% had 
not and of those that received only 47.7% had received the recommended two or more doses by 
their third trimester of pregnancy while 35.5% received only one dose (Orish et al., 2015). 
Similarly, a study conducted in Burkina Faso showed that of the 90% of pregnant women who 
attended ANC only 10.6% received the recommended doses of IPTp-SP (Brieger et al. 2013). In 
addition, studies have shown that missed opportunities among healthcare providers to administer 
IPTp-SP during ANC was evident, as a study by Sangar et al. (2010) showed that only 31.8% of 
women who attended ANC received at least two doses of IPTp-SP in Uganda. In addition, a 
systematic analysis conducted across sub-Saharan Africa showed that 72.9% of women attending 
ANC services were not administered IPTp despite high ANC attendance among pregnant women. 
As a result, showing deficiencies in the administration of IPTp among healthcare providers during 
ANC services (Andrews et al., 2015). In addition, Fawole & Onyeaso (2008) showed of the 60% 
of women who attend ANC services, only 18.7% were administered IPTp. 
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Furthermore, studies have shown that the administration of IPTp-SP remains generally low in 
Nigeria  (Onoka et al., 2012; Ameh et al., 2016). One of such studies is a study by Olorunda and 
Ajayi (2013) which showed that of the 62.2% of women who attended ANC services in South-
West Nigeria, only 26.0% received at least one dose of IPTp-SP and 4.9% received at least two 
doses of the recommended IPTp-SP. In addition, a study by Onyebuchi et al. (2014) showed that 
of the women who attended ANC in South East Nigeria, 72.1% took at least one dose of IPTp-SP 
while 59.7% took two doses of IPTp-SP and only 4.9% took a third dose despite bookings at the 
ANC. Another study conducted  by Nneka, Maxwell and Nze (2014) showed that although 
healthcare providers had adequate knowledge on IPTp-SP and its role malaria in pregnancy they 
however, had limited understanding on the best strategies to administer drugs such as IPTp-SP 
during focused ANC services. However, the study failed to use a qualitative approach to 
understand the underlying reasons behind the poor practices of IPTp administration during ANC 
services (Nneka, Maxwell and Nze, 2014). 
A current survey of the strategies to prevent malaria in south-south Nigeria showed that only 
55.95% of healthcare providers were aware of the current recommended IPTp-SP strategy of 
which 44.5% administered SP in IPTp during ANC services (Oranu, Ojule and Ordu, 2016). 
Furthermore, confusion among healthcare providers on the timing of the administration of SP in 
IPTp and whether it should be given on empty stomach was apparent in many studies (Akinleye, 
Falade and Ajayi, 2009; Oyefabi, Sambo and Sabitu, 2015; Ameh et al., 2016) . 
1.5.3 Barriers to the recommended administration of IPTp-SP  
A substantial amount of evidence has shown that the barriers to the administration and utilisation 
of IPTp-SP was largely attributable to the healthcare providers (Hill et al., 2015; Ameh et al., 
2016). One of such studies is a study by Yoder et al. (2015) which showed that healthcare providers 
in Malawi partly contributed to the low compliance of IPTp-SP as healthcare providers were not 
able to show the guidelines on IPTp administration. The same study indicated that although, 
healthcare providers displayed adequate knowledge of IPTp administration during antenatal care 
(ANC) services and the rationale behind giving pregnant women, they however showed 
uncertainty on the timing of the doses thus, resulting to the inconsistencies in the dissemination of 
IPTp-SP (Yoder et al., 2015). One major limitation of this study is that it only interviewed the 
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nurses without systematically considering the knowledge and perception of the manager or head 
of each health facility in order to elaborate on the IPTp-SP strategy (Yoder et al., 2015). 
Moreover, a recent report conducted in Mozambique by Salomão, Sacarlal and Gudo (2017)  
indicated that the steep decline between  IPTp1 and IPTp2 administration could not be entirely 
attributed to number of ANC visits but rather, the practices of the healthcare providers influenced 
the coverage of IPTp and its drop-out rate. These findings corroborate with a study conducted in 
Gambia which showed that poor knowledge on the correct timing of administration of SP was 
associated with low administration of IPTp (Brabin et al., 2009). A meta-analysis on the barriers 
to IPTp-SP showed that misunderstanding among healthcare providers on the administration of 
IPTp was a contributing barrier to the effective uptake and utilisation of IPTp-SP (Hill, Hoyt, et 
al., 2013). 
1.5.4 Issues around compliance and attitude among healthcare providers on IPTp 
administration 
A study by Obieche et al. (2015) showed that poor adherence to IPTp guideline such as poor 
routine administration of SP during ANC services among healthcare providers contributed to  the 
low administration IPTp-SP. In addition, a study conducted in Sabon-Gari local government area 
of Kaduna state, Nigeria showed that healthcare providers had limited knowledge on the timing of 
IPTp-SP administration and this contributed to its low uptake (Oyefabi, Sambo and Sabitu, 2015). 
The same study further trained healthcare providers on the recommended guideline of IPTp-SP.  
However, the study assessed the effect of training among pregnant women and not among the 
healthcare providers. Another study conducted in Ibadan, Nigeria showed that only 24.5% of the 
healthcare providers had adequate knowledge on the content and strategy of IPTp-SP of which 
only 23.1% reported to have complied with the DOT strategy (Arulogun and Okereke 2012). The 
same study found that 22.5% of pregnant women were still prescribed chloroquine by healthcare 
providers despite overwhelming evidence of its increasing resistance. One reason behind poor 
compliance of IPTp-SP was due to poor knowledge on the dissemination of the current IPTp 
strategy among the healthcare providers as the study found knowledge to be significantly 
associated with practice and compliance of IPTp-SP (Arulogun and Okereke 2012).   
A cross-sectional study conducted by Katsayal et al., (2014a) on the acceptability of IPTp-SP in 
Zaria, Nigeria found that only 50% of  primary healthcare facilities had satisfactory knowledge on 
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the administration of SP in IPTp of which only 30% of t hem were practicing DOT (Katsayal et 
al., 2014a). The study further indicated that for effective administration of IPTp as per the national 
guidelines, healthcare providers should be trained regularly (Katsayal et al., 2014a).  A similar 
study found that two-third of the primary healthcare providers in Enugu, Nigeria were not 
complying with the national IPTp guidelines as SP was administered to the pregnant women to 
take home rather than a DOT (Onoka et al., 2012). In addition, the study failed to engage with 
healthcare providers in order to understand the issues behind non-compliance of IPTp-SP and build 
capacity on addressing those issues  (Onoka et al., 2012). 
Furthermore, a study conducted in Cross-river state, south-south region of Nigeria showed that 
33% of non-utilisation of IPTp-SP was due to the non-compliance of the healthcare providers to 
practice DOT (Ameh et al., 2016). One possible explanation to this is that it could be a process 
issue on the administration of the IPTp because the healthcare providers were not practicing DOT 
(Obieche, Enato and Ande, 2015). These findings concur with the findings conducted in south-
west and northern Nigeria which showed that high level of awareness of IPTp among healthcare 
providers were important predictors on the uptake and utilisation of SP in IPTp (Akinleye, Falade 
and Ajayi, 2009; Iliyasu et al., 2012).   
A similar study conducted by Amoran et al. (2012) showed that missed opportunity among 
healthcare providers to administer IPTp-SP during ANC was evident in Nigeria as only 14.6% of 
women in rural areas of western Nigeria received at least two doses IPTp. The study further 
showed that ANC attendance was not necessarily a factor for the utilisation of IPTp-SP rather, 
routine administration of SP during ANC visits, unclear messages and limited understanding of 
IPTp-SP among healthcare providers contributed to its low administration (Amoran, Ariba and 
Iyaniwura, 2012).  A similar study highlighted the role of healthcare providers expertise in IPTp 
uptake given high ANC coverage and low IPTp refusal rate among the pregnant women (Christian 
Rassi et al., 2016).  
Furthermore, low administration of IPTp-SP was found to be a major determinant of malaria in 
pregnancy (MIP) as a study conducted in north-eastern Nigeria found that parasitaemia was higher 
in this region due to non-adherence among the healthcare providers to administer IPTp-SP 
(Muhammad et al., 2016).  In addition, the study found that a vast majority of mothers who took 
less than two doses of IPTp-SP gave birth to babies with low birth weight. Also, there was high 
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prevalence of maternal anaemia and malaria parasitaemia among mothers who reported low 
utilisation of IPTp-SP (Muhammad et al., 2016).  
1.5.5 Stock-Outs of IPTp 
On the other hand, studies have shown that stock-outs was another contributor to poor 
administration of IPTp (Hill, Hoyt, et al., 2013; Katsayal et al., 2014a). One of such studies is a 
study by  Diala et al., (2013) which showed that system-based challenges such as lack of provider 
knowledge and stock-outs of IPTp all contributed to the administration of IPTp-SP (Diala et al., 
2013). Nonetheless, a quasi-experimental study showed that stock-out of IPTp-SP may not be 
completely eliminated due to funding issues especially in countries dependent on external funding 
(Maheu-Giroux and Castro, 2014). The same study showed that simple structural and 
informational flow changes such as following of  the IPTp guidelines among healthcare providers 
could improve the administration of IPTp during ANC visits (Maheu-Giroux and Castro, 2014).  
1.5.6 Summary of the literature 
Poor knowledge, compliance and attitude among healthcare providers contributed to the low level 
of IPTp administration. Also, stock-outs contributed to the poor administration of IPTp. 
1.6 Conceptual Framework for improving IPTp-SP administration 
The Ridge-Kybele Model 
This study adapted the Ridge-Kybele Model. This model was adapted because it uses a quality 
improvement approach (selecting change agent, build capacity and learning from improvement) 
to implement interventions which has the potential to produce desired outcomes. 
The core idea behind the model is that there is need for a mechanism whereby skills are used 
together to address performance issues (Ramaswamy et al., 2015) . This model posits that 
implementation of complex interventions cannot be successful with training alone. Rather, for 
successful performance in service delivery, evidence-based interventions needs to be 
contextualized and translated to fit a particular setting then a support system such as data collection 
and coaching need to be conducted to ensure that the contextualised intervention fit into the 
context.   
In implementing the model, five steps are required which are; selection and development of change 
agents, building foundational capacity in QI and leadership, identifying performance gaps, creating 
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contextualised training modules and learning through QI. The original conceptual framework is 
attached in Appendix A. This study adapted the five steps of the Ridge- Kybele Model to improve 
the administration of IPTp during ANC services and some of the steps were modified to fit the 
context of our clinic (PHC Samaru). These steps are; selection of QI team, building QI capacity 
(consisting of meetings focusing on when and how the intervention was conducted as well as 
contextualizing the IPTp guideline), identifying implementation gaps of IPTp administration, 
training and coaching of healthcare providers and learning through QI (which consists of 
assessment of the intervention and improving IPTp administration during ANC services). These 
steps have the potential to reduce maternal morbidity and mortality due to malaria.  The modified 
conceptual model to improve IPTp administration using an integrated approach is shown in Figure 
1. 
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Figure 1: The modified Ridge-Kybele Model to improve IPTp-SP administration using an 
integrated approach.  
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CHAPTER 2: METHODOLOGY 
This chapter explains the research methodology used for this study. It discusses the study settings, 
study population, the intervention, how the data was collected and managed. This chapter also 
explains how the data was analysed and the ethical consideration of the study. 
2.1 Study design  
This is a quasi-experimental study design consisting of pre-intervention, intervention and post-
intervention components. Information on the administration of IPTp in the ANC daily register of 
pregnant women receiving ANC services at PHC Samaru (located in Sabon-Gari LGA, Kaduna, 
Nigeria) were collected at pre-intervention, intervention and post-intervention phases from 21st 
November 2016 to 27th July 2017.   
2. 2 Study setting 
The present study was conducted in PHC Samaru, Sabon-Gari local government area (LGA) of 
Kaduna state which is located in the guinea savanna area of northern Nigeria.  This area is situated 
in a malaria endemic area (Sufiyan, Umar and Shugaba, 2013; Oyefabi, Sambo and Sabitu, 2015). 
The most spoken language in Sabon-Gari is Hausa. It is an urban local government with a 
population of 286 671 in its two district of Basawa and Sabon-Gari of which 64 256 are women in 
the child bearing ages of 15-49 years (Sufiyan, Umar and Shugaba, 2013). Also, Sabon-Gari local 
government area has a total of 22 PHCs consisting of 5 health posts, 9 health clinics and 8 family 
health units. These PHCs facilities are all distributed between 6 health districts of the local 
government of which they all provide ANC and malaria services with only 6 PHCs providing ANC 
services free of charge thus, often overloaded with patients. These are PHC Jama’a, PHC Audu 
Kwari, PHC Sakadadi, PHC Basawa, PHC Samaru and PHC Muchia. This study was conducted 
in PHC Samaru at Sabon-Gari local government area because it offers ANC services and provides 
IPTp to pregnant women free of charge. In addition, PHC Samaru is easily accessible and it is one 
of the biggest PHCs in Sabon-Gari LGA.  
Study Context 
Primary healthcare Samaru provides ANC services to pregnant women three times in a week which 
is on Mondays, Wednesdays and Thursdays. Majority of the woman who attends ANC on 
Mondays are within their first and second trimester of pregnancy and these group of women are 
the majority that attend ANC services throughout the week while those that attend on Wednesdays 
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and Thursdays are within their second and third trimester of pregnancy. Prior to each pregnant 
woman being attended to individually, the healthcare providers give health talk to all the pregnant 
women attending ANC services as a group before they proceed individually to the healthcare 
provider providing ANC services. During this routine, the healthcare provider asks the pregnant 
women about any signs and symptoms they were experiencing. If any pregnant woman complains 
of any feverish symptoms, her routine/ procedure ends immediately as she is sent to the lab for 
malaria test. If she tests positive for malaria, she gets treated first before commencing with IPTp-
SP. However, in severe malaria cases the healthcare provider refer the pregnant woman to the 
teaching hospital immediately, while the pregnant woman without any signs, symptoms or 
complains of feverish feelings is administered IPTp-SP and proceeds for palpitation.  
2. 3 Study population and sampling 
Primary healthcare providers who provide ANC services at PHC Samaru constituted the study 
sample.  Twelve out of the fifteen healthcare providers in the facility were purposively selected, 
being those who provide ANC services. To achieve maximum variation of characteristics, different 
categories of healthcare providers were selected. These are auxiliary nurses, community healthcare 
providers, and ANC service providers involved in providing ANC services were recruited.  
Inclusion and exclusion criteria 
Inclusion: The study included all healthcare workers who provided ANC services at PHC Samaru 
in March 2017.  
Exclusion: Healthcare providers providing ANC services at PHC Samaru not present during the 
study period. 
2. 4 Overview of the intervention 
A QI intervention which is an integrated approach of training and coaching of healthcare providers 
on IPTp-SP intervention was implemented and tested in PHC Samaru.  This involved training of 
healthcare providers at the facility level on the administration of the recommended IPTp for two 
weeks which was followed up with coaching for a period of another two weeks. To do this, a 
quality improvement (QI) team was created and roles and responsibilities were assigned. The QI 
team comprised of practitioners in the field who are confronted with quality issues on a daily basis. 
This included the senior community healthcare workers (CHWs), midwives, auxiliary nurses and 
a QI facilitator (the researcher). The QI team came up with strategies on how best to conduct the 
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integrated training and coaching of which they chose appropriate days and time to conduct the 
training. The training sessions were conducted on ANC service days and were done in the 
afternoon as ANC services at PHC Samaru are mainly provided in the morning. This was done in 
order for the training not to interfere with the normal clinic services. To keep the project and team 
on track, the healthcare providers were fully engaged in the planning phase of the integrated 
approach to training in order to have their explicit buy-in of the intervention. Upon creation of the 
QI team, a workshop was organised in which healthcare providers were trained on the 
recommended administration of IPTp of which two training sessions were conducted over a period 
of two weeks. Four coaching sessions were conducted over a period of two weeks and the coaching 
package involved follow-up meetings, supervision and putting up wall charts with clearly 
illustrated diagram and messages to the healthcare providers on the protocol of IPTp 
administration. Training and coaching was done by the researcher with active support from the 
senior healthcare provider. The tools (protocol guide and wall charts) used were the IPTp guide 
developed by the Nigerian government which was adopted from WHO. In order for the healthcare 
providers to understand the IPTp guide clearly, the training guide was translated to “Hausa” (the 
local) language. This is because Hausa is the main language of communication in Sabon-Gari LGA 
and will enable the message in the training to be passed more effectively to the healthcare providers 
without miscommunication and or misunderstanding.  In most cases, the integrated training was 
adapted to fit a specific context of the PHC Samaru since the clinic has different mix of healthcare 
providers, skills, level of education and different level of understanding IPTp policy. For example 
the training guide was translated to the local language (Hausa) in order to have the buy-in of 
healthcare providers and engage with all participating healthcare providers. The use of 
contextualized training guide is not unique in our study as previous studies have used such 
approach (Ramaswamy et al., 2015; Rye et al., 2017).   
As part of the QI intervention process, interviews were conducted with eleven healthcare providers 
(QI team) who directly provided ANC services before the intervention to identify implementation 
gaps within the context of the clinic. This aided in providing information that contextualized the 
intervention. Prior to the intervention, the healthcare providers were administering IPTp to take 
home rather than under DOT. However, this changed during the training sessions as the healthcare 
providers (QI team) learned the procedures on how to administer IPTp as per protocol from the 
Federal Ministry of Health. As part of the training session, the healthcare providers discussed the 
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importance of administering IPTp under DOT whether the pregnant woman has eaten or not. As a 
result, IPTp was administered to eligible pregnant women receiving ANC services and the ANC 
daily register were not ticked for any pregnant women who doesn’t take IPTp-SP under DOT. In 
addition, the head of the clinic agreed to provide water and disposable cups to pregnant women 
during ANC services. In addition, the QI team discussed on the eligibility of IPTp administration. 
This includes administering the first dose of IPTp at 13 weeks of pregnancy, the second dose four 
weeks interval from the first dose and the third dose four weeks interval from the second dose. As 
part of the intervention, the healthcare providers learnt how to use the wall charts showing IPTp 
key messages as a reminder. There were also site visits for coaching, mentoring and feedback for 
any change idea that is necessary for the intervention. This motivated the healthcare providers to 
distribute available nets to the pregnant women attending ANC services. The healthcare providers 
were also trained on how to appropriately tick IPTp administration and its doses in the ANC daily 
register.  
2. 5 Data collection 
Data collected in the ANC clinic register before, during and after the intervention were used to 
estimate the proportion of eligible women administered IPTp1 and IPTp2+ over the period. All 
data were obtained from the ANC clinic register which is routinely recorded in the National Health 
Management Information System (NMHIS) health facility daily ANC register at Samaru PHC.   
Data recorded for four months (sixteen weeks) i.e. from 21st November 2016 – 09th March 2017 
at the PHC were analysed as the pre-intervention phase. This was followed by four weeks of 
integrated training (two weeks of training and two weeks of coaching) which was from 13th March 
to 6th April 2017 which was analysed as the intervention phase.  Data recorded four months (sixteen 
weeks) post-intervention from 10th April to 27th July 2017 were analysed as the post-intervention 
phase. Although, the data were collected on specific days of the week during ANC services they 
were, summarized and analysed on a weekly basis. 
A copy of the National Health Management Information System (NHMIS) health facility daily 
ANC register used to collect information at the ANC, from where the required data for this study 
was extracted is attached in Appendix B. Also, attached in Appendix C is the list of variables 
extracted and analysed for this study. 
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2. 6 Implementation measures and outcome 
The outcome measures are proportion of eligible pregnant women administered IPTp1 and 
IPTp2+. The national guideline describes eligibility for IPTp1 as women who are in their second 
trimester of pregnancy (gestational age thirteen weeks and above) with their first ANC visit within 
that period. Eligibility for IPTp2+ in this context refers to ANC clients who had received IPTp1 
with at least four weeks interval. These measures were calculated from data collected from the 
routine health facility daily ANC register.   
The proportion of those eligible for IPTp1 was calculated by dividing the number of pregnant 
women administered IPTp1 (numerator) by number of eligible women for IPTp1 (denominator) 
multiplied by 100. The denominator i.e. number of eligible women for IPTp1 was calculated using 
the eligibility criteria of pregnant women in their gestational age 13 weeks and above with their 
first ANC visit. The proportion of those eligible for IPTp2+ was calculated by dividing the number 
of pregnant women administered IPTp2+ (numerator) by number of eligible women for IPTp2+ 
(denominator) multiplied by 100. The denominator i.e. number of eligible women for IPTp2+ was 
calculated using the eligibility criteria of pregnant women who had received IPTp1 with at least 
four weeks interval. 
2. 7 Data Management 
Selected variables were extracted from the NMHIS into excel spreadsheet. The data entry 
spreadsheet was double checked to ensure accuracy and completeness of the data. 
2. 8 Data Analysis 
Objective 1: To determine the level of IPTp administration among healthcare providers at PHC 
Samaru. 
The number of women administered IPTp doses and the number of eligible women for IPTp doses 
were used to calculate the proportion of eligible women administered IPTp doses. Line graphs 
were used to display the levels of (trend in) IPTp administration over the sixteen weeks pre-
intervention phase. 
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Objective 2: To conduct an integrated training and coaching intervention aimed at improving 
the administration of IPTp among healthcare providers at PHC Samaru. 
For QI interventions, context specificity is important in identification of implementation gaps in 
order to conduct interventions that are tailored to the unique needs and context of different 
populations (Wandersman et al., 2008). As a result, in-depth interviews were conducted among 
healthcare providers prior to the intervention in order to determine the implementation gaps in 
IPTp administration within the context of the clinic using a developed interview guide (Appendix 
D). The key findings of the interview are: inconsistent implementation of national guideline on 
IPTp, inconsistencies with timing of IPTp administration, poor knowledge of IPTp and poor 
knowledge on data entry in the ANC daily register among healthcare providers. These corroborate 
the findings of the Oyefabi, Sambo and Sabitu (2015) study and shows that the low level of 
knowledge of the IPTp guideline still persist among the healthcare workers in this PHC. See details 
of the interview results in Appendix E. The findings also shows that the selected intervention for 
the study is indeed appropriate as the need to retrain and follow up with coaching are apparent in 
the setting. 
Line graphs were plotted over the intervention period to display the level and patterns of IPTp 
administration over the intervention period. 
Objective 3: To measure the effect of the integrated training and coaching intervention on IPTp 
administration at PHC Samaru. 
Run charts were plotted over the entire duration of the study (pre-intervention, intervention and 
post intervention periods) to measure the effect of the integrated training and coaching intervention 
on IPTp administration. Run charts are graphs plotted over time which displays the trend and 
pattern of a process (Anhøj and Olesen, 2014). All data were analysed retrospectively sixteen 
weeks prior to the intervention, four weeks of the intervention (training two weeks which was 
followed up with coaching for two weeks) and sixteen weeks post-intervention. 
2.9 Limitations of the data 
1) Inconsistencies in data entry, errors in data entry and missing data on IPTp were prominent 
in the ANC daily register. For example, some healthcare providers ticked the column of 
both IPTp1 and IPTp2+ on the same day for the same pregnant women. As a result, the 
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data may not reflect the true situation of IPTp administration in the clinic. However, this 
was controlled for by recording the data as IPTp2+ ( The QI team which consists of 
healthcare providers had meetings on the inconsistencies in the data entry of which some 
healthcare providers admitted that both IPTp1 and IPTp2+ were ticked for the same day 
for pregnant women who had received IPT1 in their previous visit thus, indicating that 
entering the data as IPTp2+ is more accurate in this case). 
2) IPTp1 was administered to some pregnant women at less than 13weeks of gestational age 
resulting at times, in higher number of pregnant women administered IPTp1 compared to 
number of eligible women for the dose. 
3) The denominator used in calculating proportion of eligible women administered IPTp1 and 
IPTp2+ respectively (i.e. the number of eligible women for IPTp1 and IPTp2+) were not 
refined. For instance, some pregnant women were administered IPTp1 but were considered 
ineligible because it was not their first visit but they were not administered IPTp1 at 
previous ANC visits due to factors such as stock-outs or presenting with malaria, which 
had to be treated first before administration of IPTp. Hence, the number of eligible pregnant 
women used as denominator may be an underestimation of the total number of eligible 
pregnant women administered IPTp.  
4) There was no eligibility record (i.e. gestational age and number of ANC visits) for some 
pregnant women administered IPTp1 and IPTp2+. Thus, they were excluded from analysis. 
Approximately 8.03% of pregnant women records extracted from the ANC daily register 
were excluded from the analysis. 
5) The ANC daily register was not designed to collect information for this evaluation. Thus, 
it limits the way the denominator (number of pregnant women eligible for both IPTp1 and 
IPT2+) was calculated. To control tis challenge, an eligibility criteria was set for the 
denominator (Check implementation measures and outcomes page 16). 
2. 10 Ethical consideration  
Written informed consent were obtained from the healthcare providers to participate in the study. 
Standard ethical principle of confidentiality and privacy were adhered to as all information on the 
data were de-identified and kept secured. Permission was sought from Kaduna State Primary 
Healthcare Development Agency (approval no: KDSPHCA/SF/ADM/20/VOL.1/P.89 – Appendix 
F), director of the PHC and head of the PHC in order to use the daily ANC clinic register and 
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conduct the integrated training. Ethical approval was obtained from the Ministry of Health, Kaduna 
State Research Ethics Committee in Nigeria (approval no: MOH/ADM/744/VOL1/502 – 
Appendix G) and the University of Witwatersrand Human Research Ethics Committee (approval 
no: M161171 – Appendix H). 
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CHAPTER 3: RESULTS 
 
This chapter focuses on reporting the results obtained from the data analysed.  
A total of 36 ANC visit weeks were observed between 21st Nov 2016 and 27th July 2017. For each 
ANC visit, the maximum number of pregnant women administered IPTp1 and IPTp2+ per week 
were 59 and 64 respectively.  The average number of pregnant women who received IPTp1 and 
IPTp2+ were 25.76 and 35.36 respectively. Table 1 shows the descriptive summary of the IPTp 
doses. 
 
Table 1: Descriptive Statistics of IPTp administration 
  IPTp1 IPTp2+ 
Minimum  no of pregnant women administered IPTp 
per week during the 36 weeks study period 
0 0 
Maximum  no of pregnant women administered IPTp 
per week during the 36 weeks study period 
59 64 
 
Mean (SD) 25.76 (13.21) 35.36 (17.69) 
 
 
3.1 Pre-intervention Level of IPTp Administration  
The level of IPTp administration to eligible women varied across IPTp doses. The mean level for 
IPTp1 administration pre-intervention was 105.85% (SD: 29.28). The levels were relatively stable 
from Week 1 to Week 10 after which the pattern became undefined. There was overestimation of 
IPTp1 as 8 of the 16 weeks in the pre-intervention phase i.e. weeks 3, 5, 7, 8, 11, 13, 15 and 16 all 
had more than 100% of eligible women administered IPTp1. The mean level for IPTp2+ 
administration pre-intervention was 75.20% (SD: 16.89). Week 7 had the highest level of IPTp2+ 
administration of 98.04%. However this dropped in subsequent weeks and later increased in weeks 
14, 15 and 16. The patterns of IPT2+ administrations shows the levels of IPTp2+ administration 
were erratic. The pattern of IPTp1 and IPTp2+ administration is shown in Figures 2 and 3 
respectively. 
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 Figure 2: IPTp1 administration pre-intervention 
 
 
 
 
Figure 3: IPTp2+ administration pre-intervention 
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3.2 The Intervention Process 
An integrated training and coaching approach was the strategy used in the implementation of the 
intervention in order to improve IPTp administration. The integrated training was conducted for a 
period of one month which comprises of two weeks training and two weeks coaching. The findings 
in the pre-intervention interview showed that there were inconsistent implementation of national 
guideline on IPTp, inconsistencies with timing of IPTp administration, poor knowledge on IPTp 
administration and poor knowledge on data entry in the ANC daily register among healthcare 
providers. As a result, training was conducted to fit the implementation gaps of IPTp identified 
within the context of PHC Samaru. The Ridge-Kybele framework was used as a guide for the QI 
intervention. The process and content of the intervention is shown in Figure 4. 
Figure 4: A refined and more detailed version of the Ridge-Kybele framework showing the 
process of the QI intervention.  
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3.2.1 Assessment of IPTp1 administration over the intervention period  
During the intervention period, the proportion of eligible pregnant women administered IPTp1 was 
100% in the first week. This dropped in the second week to 66.67% and increased to 72.72% and 
98.78% in the third and fourth week of the intervention period, respectively. Figure 5 shows the 
pattern of the IPTp1 administration during the four weeks of the intervention period. 
 
 
Figure 2: IPTp1 administration over the intervention period 
 
3.2.2 Assessment of IPTp2+ administration over the intervention period  
During the intervention period, the proportion of eligible pregnant women administered IPTp2+ 
was 88.89% in the first week. This dropped in the second week to 81.03% and further dropped to 
51.02% in Week three. The administration of IPTp2+ increased to 90.14% in Week four of the 
intervention phase. Figure 6 shows the pattern of IPTp2+ administration during the four weeks of 
the intervention period. 
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Figure 3: IPTp2+ administration over the intervention period 
 
3.3 Effect of the integrated training and coaching on IPTp administration 
Although the study period was 36 weeks, analysis is restricted to the first 30 weeks (meaning 10 
weeks post intervention data points) only due to stock-outs of IPTp in Weeks 31, 32, 35 and 36. 
This affected IPTp administration at the PHC over the last six weeks of the study. The median 
proportion of eligible pregnant women administered IPTp1 were 101.16%, 84.75% and 100% 
across the pre-intervention, intervention and post-intervention periods respectively which suggests 
improvement in the post-intervention assessment. In Weeks 11, 13 and 16 (of the pre intervention 
period) there were astronomical points as a number of women that received IPTp1 during these 
weeks were not eligible. The administration on IPTp1 dropped in the 1st and 2nd week of the 
intervention period and slightly increased in the 3rd and 4th Week of the intervention period. The 
results presented in Figure 7 suggest that the administration of IPTp1 post-intervention (i.e. Weeks 
21 -30) was stable as the data crosses the median line six times i.e. 7 runs1. This indicates that the 
process of IPTp1 was within normal variation over the post-intervention period. According to the 
run chart rules for 10 data points the lower limit for number of runs is 3 and upper limit is 8. As a 
                                                          
1 Run chart is a measure of line graph plotted over time with the median line shown in order to identify whether 
there is an improvement or degradation in a process (Anhøj and Olesen, 2014). Runs are a series of data points that 
fall either above or below the median. Too frequent or too few runs indicate a non-random variation. Expected 
number of runs are based on a table adapted from Swed and Eisenhart. 
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result, having runs between 3 and 8 suggests the process is within normal variation2. (See 
Appendix I for a more detailed run chart rules).  
 
  
 
                                                          
2 Normal variation in run charts indicate a natural part of the process i.e. the process is usual (variation occurs in all 
processes). 
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Figure 4: Run chart showing the effect of the integrated training on IPTp1 administration 
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The median proportion of eligible pregnant women administered IPTp2+ were 76.14%, 84.96% 
and 80.94% across the pre-intervention, intervention and post-intervention periods respectively. 
There was evidence of a non-random pattern of IPTp2+ administration as there was a downward 
shift in the administration of IPTp2+ from Weeks 8 to 13. Also, there was a downward trend of 
IPTp2+ administration from Weeks 14 to 18 which was within the pre-intervention and 
intervention period. There was an upward shift immediately after the intervention which was from 
Weeks 21 to 26 suggesting some improvement of IPTp administration post-intervention. The 
numbers of missing data for IPTp were more frequent in IPTp2+ as compared to IPTp1.  Figure 8 
shows the effect of an integrated training on IPTp2+ administration.  
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Figure 5: Run chart showing the effect of the integrated training on IPTp2+ administration
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CHAPTER 4: DISCUSSION 
In this study, a quality improvement approach consisting of training and coaching of healthcare 
providers was used to improve the administration of IPTp at Samaru primary healthcare clinic in 
Sabon-Gari local government area, Kaduna State, Nigeria. This study results showed over-
estimation of IPTp1 prior to the intervention and suggests that the process of IPTp1 administration 
was relatively stable post-intervention. On the other hand, there was evidence of a non-random 
variation3 in the administration of IPTp2+ over the pre-intervention period. This indicates a change 
in the normal process, possibly due to other factors that influence the normal IPTp administration 
pattern. However, an upward shift was observed in the immediate post-intervention period, 
suggesting an improvement in the administration of IPTp2+ which may be due to the intervention. 
The numbers of missing data for IPTp were more frequent in IPTp2+ as compared to IPTp1. Stock-
outs were found to be a major challenge that hampered the administration of IPTp in the post-
intervention assessment.   
 
 
 
 
 
 
 
 
 
  
                                                          
3 Non-random variation in run charts indicates the process is unusual (due to something outside the system) which 
causes recognizable trends, shifts or pattern in the data. 
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4.1 Intervention Impact 
This study found that the process of IPTp1 administration was relatively stable post-intervention. 
For IPTp2+, there was an upward shift suggesting immediate improvement in its administration 
post-intervention. This is consistent with other findings which showed significant improvement in 
the administration of IPTp post-training of healthcare providers (Ng and Odhiambo, 2014; 
Oyefabi, Sambo and Sabitu, 2015). Similarly, Arulogun, O.S., and Okereke (2012) indicated that 
knowledge of IPTp among the healthcare providers was significantly associated with practice as 
healthcare providers who had received training on IPTp were more likely to administer the pills as 
per national guidelines. To support these findings, the Interactive Systems Framework (ISF) shows 
that providers form part of the delivery system in an intervention and it is necessary to train 
healthcare providers regarding the implementation of interventions in order to have the desired 
outcomes (Wandersman et al., 2008). Furthermore, the National Implementation Research 
Network (NIRN) identified the role of training and coaching of providers as implementation 
drivers, complementing each other to yield consistent and desired outcomes, as was the case in 
this study (NIRN (National Implementation Research Network) FCDI, 2017). Moreover,  Durlak 
and DuPre (2008) emphasized the importance of training and monitoring of providers for 
improvement in healthcare practice within a particular context.  
  
Although this study showed some improvement, the integrated training and coaching intervention 
on IPTp administration may not have reached its full impact due to the short post-intervention 
assessment. Durlak (2011) indicated that the impact of an intervention may not be noted in a short 
period rather, it may take over a year to achieve quality implementation as there is need for patience 
in estimating the true value of some interventions.   
 
4.2 Overestimation of IPTp 
Overestimation of IPTp1 was found in the baseline record review and pre-intervention interview. 
This is consistent with other findings which showed that healthcare providers administer the first 
dose of IPTp (IPTp1) to pregnant women receiving ANC services regardless of their eligibility 
status  (Anchang-kimbi et al., 2014; Exavery et al., 2014). On the other hand, Hurley et al., (2016) 
showed that there was underestimation of IPTp2+ as healthcare providers seldom fail to record 
IPTp2+ administered to pregnant women in the ANC daily register. This was consistent in our 
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study as there were a lot of missing data of IPTp2+ thus, resulting in underestimation. The above 
findings concur with a study conducted by Gross et al., (2011) which showed that as compared to 
IPTp2+, healthcare providers were more likely to administer and record IPTp1 as they were 
reluctant in administering IPTp2+ considering the pregnant women had received the first dose in 
their previous ANC visit. 
 
4.3 Stock-outs  
Stock-outs were found to be a major challenge that hampered the administration of IPTp in the 
post-intervention assessment of this study as without IPTp there is no administration of the pills 
thus, no record on its administration. This resulted in missed opportunities of IPTp administration 
among pregnant women receiving ANC services. These findings are similar to previous findings 
which showed that, missed opportunities at health facilities contributed to the greatest losses in 
IPTp implementation strategies (Hill, Hoyt, et al., 2013; Doku, Zankawah and Adu-Gyamfi, 2016). 
Similarly, other studies have shown IPTp stock-outs as a major barrier to its administration during 
ANC services  (Arulogun, O.S., and Okereke, 2012; Katsayal et al., 2014; Ameh et al., 2016; 
Doku, Zankawah and Adu-Gyamfi, 2016). Furthermore, Rassi et al., (2016) showed that  ANC 
visits were not assurance for IPTp administration. Moreover, based on the pattern of IPTp 
administration in this study some pregnant women receiving ANC services were not administered 
IPTp due to stock-outs thus, attributing for missed opportunities. These findings further 
corroborate with other findings which showed that while ANC attendance is high, IPTp 
administration remains low with a high dropout rate of IPTp2+ from IPTp1 and stock-out was a 
contributing factor to these drop-out rates (Andrews et al., 2015; Salomão, Sacarlal and Gudo, 
2017).  However, Hill, Dellicour, et al. (2013)  showed a contradictory report by indicating that 
stock-outs were unlikely to be the primary issue of low compliance of IPTp administration as the 
process of IPTp administration (such as administration of IPTp under DOT, checking for eligibility 
and screening for malaria) among healthcare providers during ANC services could contribute to 
low administration. 
 
4.4 Data quality 
Our study found that there were poor data quality in the ANC daily register as missing data and 
poor data entry were evident for both IPTp1 and IPTp2+. The numbers of missing data is more 
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frequent in IPTp2+ compared to IPTp1. These findings concur with a study conducted by 
Ashwood-Smith et al. (2002) which showed that there were inconsistences of IPTp records in the 
ANC daily register and in some cases the second doses of IPTp i.e. IPTp2 is often not administered 
or administered but not ticked in the record as healthcare providers do not check the records 
properly to determine whether the pregnant women receiving ANC services had received the first 
dose. Furthermore, healthcare providers often miscount the weeks of previous IPTp administration 
and mistakenly calculate that the second dose was too soon to be administered (Ashwood-Smith 
et al., 2002).  
 
4.5 Strength of the study  
A major strength of the study is that the use of a QI approach of training and coaching improved 
the administration of IPTp. Also, the use of the routine ANC daily register provides the opportunity 
for making comparison of IPTp administration across different ANC weeks of the pre-intervention, 
intervention and post-intervention durations. Furthermore, the routine ANC daily register shows 
the natural variation of IPTp administration within the context of the clinic. 
 
4. 6 Limitations of the study 
1) The study was prone to information bias as the use of secondary data from the routine data 
system (ANC register) is known to have poor data quality which is occasioned by inadequate 
training of data officers resulting in fluctuations in data reporting rates. Regardless of these 
challenges, the routine data is still acceptable and used in health programmes and policy 
making across all levels of the health system (Eboreime, Abimbola and Bozzani, 2015).  
2) The post intervention period was short. However, Durlak (2011) indicated it may take 
considerable periods before impacts emerge.  
3) The study was conducted in real life settings thus, could not control for confounders such as 
stock-outs as procurement of IPTp were beyond the scope of this study. Moreover, stock-
outs affected the impact of the post-intervention assessment as there were high levels of 
stock-outs in the post-intervention phase. This resulted in bias in terms of comparing pre and 
post-intervention outcomes. Also, stock-outs may have affected healthcare providers’ 
compliance with the IPTp guidelines in improving the administration of IPTp which was the 
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main aim of this study as they could not administer IPTp to pregnant women receiving ANC 
services. 
4) The lack of post-intervention interview limits the understanding of the factors that affect the 
intervention outcome.  
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CHAPTER 5: CONCLUSION AND RECOMMENDATIONS  
5.1 Conclusion 
In conclusion, the QI approach of integrated training and coaching intervention carried out in this 
study suggested improvement in IPTp administration within the context of Samaru PHC.  
Several challenges were identified, including stock-outs and poor quality of using ANC daily 
register which affected the real impact of the intervention assessment. 
5.2 Recommendations 
 Future studies should consider a longer post-assessment duration in order to yield desired 
outcomes. 
 To yield desired outcomes in QI interventions, there is need for regular training and 
coaching of healthcare providers that will yield insights regarding the quality of IPTp 
administration within a particular context.  Also, regular and consistent monitoring of 
healthcare providers entering routine ANC daily register could reduce errors and improve 
the quality of ANC daily register which will yield reliable results. 
 A reliable IPTp supply system should be set up from procurement stage through, storage 
and distribution to the clinic in order to avoid stock-out. This will improve the 
administration of IPTp during ANC visits and reduce the rate of missed opportunities 
among pregnant women receiving ANC services. 
 Process measures which uses the actual process of healthcare delivery as an indicator of 
quality (by analysing healthcare providers’ activities in order to determine whether IPTp 
was administered according to the guidelines) should be considered in future studies. 
 There should be multiple test of change (i.e. different intervention cycles) in order to adjust 
and make changes during an intervention as this is ideal in QI interventions. This has 
proven to yield desired outcomes.  
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APPENDICES 
Appendix A: The Ridge-Kybele model theory of change 
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Appendix B: ANC Daily Register (Part I) 
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ANC daily register part II 
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Appendix C: Data extraction form 
Data extraction form (Information extracted from the ANC daily register) 
Weeks IPTp1 No of pregnant 
women eligible for 
IPTp1 
IPTp2+ No of pregnant 
women eligible for 
IPTp2+ 
1 
    
2 
    
3 
    
4 
    
5 
    
6 
    
7 
    
8 
    
9 
    
10 
    
11 
    
12 
    
13 
    
14 
    
15 
    
16 
    
17 
    
18 
    
19 
    
20 
    
21 
    
22 
    
23 
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25 
    
26 
    
27 
    
28 
    
29 
    
30 
    
31 
    
32 
    
33 
    
34 
    
35 
    
36 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 46 
 
Appendix D: Semi-structured interview guide 
Semi-structured Interview Guide 
Let me begin by asking you a few questions about your job. 
What is your job title?   
How long have you been in your current role? 
Role and responsibilities 
What are your role and responsibilities with regard to attending to pregnant women in this facility/  
Which malaria in pregnancy interventions are being implemented in this clinic?  
Have you had previous training on IPTp administration? 
How important is the administration of IPTp during ANC services as compared with other areas 
you are responsible for? 
IPTp guidelines  
At what age in pregnancy are you supposed to administer IPTp1? 
At what age in pregnancy are you supposed to administer IPTp2+? 
Do you administer IPTp under Direct Observed Therapy (DOT)? 
Do you administer IPTp in an empty or full stomach? 
Are there clean drinking water available during ANC? 
According to the information gotten from this clinic’s ANC record on IPTp, there is a huge 
difference in the administration of IPTp1 and IPTp2+.  What do you think are the main reasons 
why more pregnant women were being administered IPTp1 than IPTp2+? 
Does your clinic have a plan with regard to increasing IPTp administration? 
ANC daily register   
When do you tick IPTp in the ANC daily register? 
What are the challenges in terms of recording this information? 
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Are there difficulties in terms of distinguishing between the timing of IPTp1 and IPTp2+ 
administration? 
In your opinion, how could the administration of IPTp be better improved within this clinic? 
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Appendix E: Implementation gaps 
Appendix E shows the characteristics of the healthcare providers’ interviewed. Healthcare 
providers were interviewed in order to identify the implementation gaps of IPTp administration 
within the context of the clinic. Interviews were audiotaped and these were transcribed and 
translated into English Language. The data were then cleaned and imported into QDA miner. 
Transcribed interviews were coded and thematic analysis was done in order to identify the 
implementation gaps in IPTp administration within the context of a PHC. 
Appendix E: Characteristics of Healthcare Providers 
 
 
 
 
 
 
Interviews were audiotaped and these were transcribed and translated into English Language. The 
data were then cleaned and imported into QDA miner. Transcribed interviews were coded and 
thematic analysis was done in order to identify the implementation gaps in IPTp administration 
within the context of PHC Samaru. These includes, inconsistent implementation of national 
guideline on IPTp, inconsistencies with timing of IPTp administration, poor knowledge on IPTp 
and poor data entry. 
Inconsistent implementation of national guideline on IPTp  
While the national policy reveals that IPTp could be taken in either empty or full stomach, there 
were misperceptions amongst healthcare providers that IPTp should not be taken on an empty 
stomach. As a result, healthcare providers administered the pills to pregnant women to take it home 
and instructed them to take it after meal thus, opening up chances that they could either decide not 
to take the pills or forget to take it. 
“Some of the pregnant women do say they haven’t eaten (taken breakfast), so we give them 
to take home since you know it is necessary to eat. That’s why we give them to take home”.  
(Healthcare provider #02)  
Job category Gender Frequency 
Auxiliary nurse Female 5  
CHEW Female 4 
ANC service provider 
(Support staff) 
Female 2 
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Although, the healthcare providers administer SP for the pregnant women to take home, they were 
however not confident that the pregnant women actually take it at home. Regardless of these 
doubts, the healthcare providers still administer the IPTp to the pregnant women to take home. 
“We (healthcare providers) are not sure of the pregnant women taking IPTp at home” 
(Healthcare provider #03). 
Inconsistencies with timing of IPTp administration    
Despite high levels of ANC attendance, missed opportunities were prominent amongst pregnant 
women attending ANC services as pregnant women eligible for IPTp-SP were not administered 
IPTp-SP. Thus, indicating that there were deficiencies in IPTp administration at ANC services. 
Pregnant women in gestational age 13 weeks and above attending ANC services for the first time 
were not administered the first dose of IPTp-SP. Consequently, pregnant women attending ANC 
services for the second time who received IPTp1 for their first visit were not administered the 
second dose (IPTp2). Furthermore, some pregnant women were administered the first dose of IPTp 
at gestational age 28 weeks and above even though they had previously attended the first ANC 
visit as a result, they were administered IPTp at later stages of pregnancy which subsequently 
results in missed opportunities of taking the three recommended doses of IPTp throughout their 
pregnancy period.  
“We the healthcare providers also detected the mistake of poor timing of IPTp 
administration as some pregnant women eligible for IPTp doses were not administered”. 
(Healthcare provider #03). 
Furthermore, there was high compliance with IPTp1 administration as compared to IPTp2+ as 
there were missed opportunities for those doses (IPTp2+). Healthcare providers were reluctant to 
administer IPTp2+ and in some cases they were unwillingly to check the client’s record for 
eligibility in order to determine if they should be administered IPTp-SP or not. 
“When the pregnant women come for ANC it’s like my colleagues (healthcare providers)   don’t 
remember to administer IPTp2 to them” (Healthcare provider #03).Furthermore, the policy 
reveals that IPTp should be given from gestational age 13weeks and above. However, healthcare 
providers administered IPTp to pregnant women as early as 8 weeks which is potentially harmful 
to the foetus.  
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“We administer the first dose at least two months of pregnancy”. (Healthcare provider 
#01). 
Poor knowledge on IPTp among healthcare providers 
Poor knowledge on SP among healthcare providers contributed to the low administration of the 
pills especially when it is not administered under DOT. Majority of healthcare providers know of 
SP but don’t understand its use and importance. A senior healthcare provider for ANC services 
explained that those directly involved in the ANC services had limited knowledge on what SP is 
and its role in malaria in pregnancy. 
“What needs to be changed is that those directly involved in providing ANC services to 
pregnant women should know actually what IPTp is? What actually IPTp does to the 
pregnant women, why that pregnant woman really needs that IPTp? Because if I am 
handling a drug, I don’t know the importance of what I am doing then…” (Healthcare 
provider #03) 
In addition, poor knowledge on IPTp among healthcare providers contributed to missed 
opportunities and low administration of the pills amongst eligible pregnant women receiving ANC 
services. 
“If they ask the healthcare providers conducting the ANC if they know the importance of 
IPTp, what malaria in pregnancy is…? What you told me (errors in the ANC records and 
missed opportunity amongst pregnant women) you wouldn’t have detected any deficiencies 
such as some clients receiving ANC services not being administered IPTp” (Healthcare 
provider #03). 
According to the policy, IPTp should be administered to eligible pregnant women under 
observation regardless of their age or gestational ages. However, some healthcare providers had 
limited understanding of this, as they administered IPTp under observation to pregnant women in 
their late gestational age while those in their early gestational age were allowed to take it home.  
“Like pregnant women that attended ANC services yesterday (Wednesday) we administer 
IPTp under observation in our presence because they are old. But on Mondays and …… 
we administer it to them to take home”. (Healthcare provider #02).  
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Despite the known side effects of SP such as fever, dizziness, rashes amongst others, it is generally 
well tolerated. However, healthcare providers had limited knowledge on this and do not administer 
it to pregnant women who complain of potential side effects.  
“Some of the pregnant women complain of side effect so we don’t administer it to those 
that complain. (Healthcare provider #02). 
Poor data entry 
Baseline data from the ANC daily register showed poor quality of data entry. This is consistent 
with what the healthcare providers revealed on data entry. The healthcare providers explained the 
errors in the ANC daily register as a result of inadequate knowledge on entering the data amongst 
themselves. 
“The challenges just like I have said. The healthcare providers entering the records is not 
entering what was administered to the pregnant women card because of inadequate 
knowledge”. (Healthcare provider #03) 
Furthermore, inconsistencies in data entry were dominant in the ANC daily record as healthcare 
providers ticked IPTp for pregnant women that were not administered the pills and fail to tick IPTp 
for those administered. Thus, resulting in underestimation and overestimation of IPTp 
administration in some ANC records. 
“We the healthcare providers administer IPTp to pregnant women but maybe sometimes 
we fail to put it in record” (Healthcare provider #01)  
Inadequate knowledge on data entry of the daily ANC record resulted in healthcare providers less 
concerned about the errors in the record as a result, reluctant in improving the quality of data entry 
and they thought the errors in the ANC daily register were not vital. 
“Nobody is perfect. But the error isn’t a lot in the register. Or is it a lot?” (Healthcare 
provider #01).  
The review of the baseline data and the baseline IDIs showed inconsistent reporting of missing 
data and inappropriate methods of reporting missing data. Inappropriate method of reporting IPTp-
SP and missing data were more dominant in IPTp2+ as compared to IPTp1. In addition, healthcare 
providers ticked IPTp1 and IPTp2 at the same time for the same ANC visit of a pregnant woman. 
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This resulted in bias and loss of statistical precision and power of the data extracted from the ANC 
daily register.  
“It was based on the initial training, we the healthcare providers were thinking we will 
tick both columns of IPTp1 and IPTp2 if the women have attended both ANC visits. But 
they later told us it should be ticked based on their specific ANC visits …” (Healthcare 
provider #01). 
Furthermore, healthcare providers were reluctant to check the previous ANC record of the 
pregnant women to determine if they were administered IPTp in their previous ANC visit thus, 
fail to administer IPTp2+ to eligible pregnant women receiving ANC services. 
“Some of my colleagues (healthcare providers) don’t remember to go through the previous 
record of the pregnant women in order to determine whether she was administered IPTp 
or not”. (Healthcare provider #03). 
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Appendix F: Letter of research authorisation 
 (Attached is letter authorisation from the research site) 
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Appendix G: Kaduna State ministry of health research clearance certificate 
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Appendix H: Ethics clearance certificate from Wits HREC 
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Appendix I: Table showing the description of the run charts 
 
 
Rules Description 
Rule 1 (Shift) Six or more consecutive data points either all above or all 
below the median line. This suggests a non-random 
pattern of data. 
Rule 2 (Trend) Five or more consecutive data points either going up or 
going down. 
Rule 3 (Runs) Runs are a series of data points that fall either above or 
below the median. Too frequent or too few runs indicate 
a non-random variation. Expected number of runs are 
based on a table adapted from Swed and Eisenhart. 
Rule 4 (Astronomical data) Astronomical data points are data that are distinctly 
extraordinary in relation to the other data points. 
 
(Anhøj and Olesen, 2014) 
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Appendix J: Participants’ information sheet 
PARTICIPANTS’ INFORMATION SHEET 
Good Day 
My name is Simbiat Sophia Nuhu and I am a Masters student in the Division of Epidemiology and 
Biostatistics, School of Public Health at the University of the Witwatersrand, Johannesburg, South 
Africa.  
I am conducting a study to improve the administration of Intermittent Preventive Therapy using 
sulfadoxine pyrimethamine (IPTp-SP) among healthcare providers through an integrated approach 
to training. This will involve training of healthcare workers providing antenatal care (ANC) 
services at primary healthcare Samaru which will be followed up with coaching. 
The reason why I am conducting this study is to improve the IPTp administration among healthcare 
providers in Samaru Primary Healthcare Centre (PHC) at Sabon-Gari local government area of 
Kaduna state. 
Being that you are a healthcare provider, I would like to train you on the administration of the 
recommended IPTp. It is hoped that the integrated training will provide useful approach to 
healthcare providers on the administration of IPTp with regards to the national guideline. Before 
you decide to take part, you need to understand why the research is being conducted and what 
would be required of you. Therefore, take your time to read this information sheet carefully. Please 
ask any question if anything you have read is not clear or would like further information. 
The training will last for a period of two weeks and the training content will be translated into 
Hausa language for easy understanding. In these two weeks, we will come up with a team from 
PHC Samaru in order to choose the appropriate time and days to conduct the training.  The team 
will be made up of healthcare providers providing ANC service in Samaru PHC. This means you 
will be part of the team. The training will be followed up with coaching which will last for two 
weeks. The coaching package will involve follow-up meetings, supervision and putting up wall 
charts with clearly illustrated diagram and messages to the healthcare providers on the protocol of 
IPTp administration. 
As a healthcare provider in this clinic you are selected to further participate in our interview on 
IPTp policy. Also, during some ANC visits days, you will be observed on the processes of IPTp 
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administration. The researcher will ensure confidentiality and anonymity of all information gotten 
from you. 
If you decide to take part in this study, be assured that your participation is voluntary and you are 
free to withdraw at any time without giving any reason. There are no risk, penalty or loss of benefits 
whether you participate or not. 
If you have any concerns or questions regarding any aspect of this study or wish to obtain a copy 
of the results of the study, please kindly contact me on; 
Name: Simbiat Sophia Nuhu        Tel: (+234)8176620273 
Email: nuhu_sophia@yahoo.com ; ssnuh1@gmail.com 
Dr. Latifat Ibisomi (Supervisor)  
Senior Lecturer and Course Coordinator,  
School of Public health,  
The University of the Witwatersrand.  
Email: Latifat.Ibisomi@wits.ac.za  
 
In case of any complaint or other concerns about any aspect of this study, please get in touch with 
the Ethics Committee on the following contacts:  
Chairperson: peter.cleaton-jones1@wits.ac.za  
Administrators - Ms Zanele Ndlovu/ Mr Rhulani Mkansi/ Mr Lebo Moeng  
Tel: 011 717 2700/2656/1234/1252  
Email: HREC-Medical.ResearchOffice@wits.ac.za 
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Appendix K: Informed consent form 
Informed Consent Form for In-depth Interviews 
I                                                    consent to participate in a training intervention on improving the 
administration of Intermittent Preventive Therapy using sulfadoxine pyrimethamine (IPTp-SP) 
among healthcare providers in Primary Healthcare centre Samaru which is situated in Sabon-Gari 
local area of Kaduna state, Nigeria. The study is being conducted by Simbiat Sophia Nuhu; a 
Master’s student from University of the Witwatersrand, Johannesburg, South Africa.  
I confirm that: 
 I was provided with an information sheet that explained what the study is about. I have read 
and understood the information about the study as provided in the information sheet.  
 I have also consented that the training intervention will be followed up with coaching. Thus, I 
understand I will be involved in follow-up meetings and I will be supervised after the training.  
 I understand I will be observed during ANC services. 
 I may, at any stage, without prejudice, withdraw my consent and participation in the study. 
 I understand that I will not be paid for participating in the study.  
 It has been clearly explained to me that the research is confidential and anonymous. I.e. what 
I say will not be linked to me as a person and the information obtained from this study will 
only be used for research purposes. 
 I have had sufficient opportunity to ask questions (of my own free will) and declare myself 
prepared to participate in the study.  
 It has been clearly explained to me that information from this research may be used in a thesis 
report, publications, presentations or conferences. 
 
PARTICIPANT: 
 
 
Signature                                                                                   Date  
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Consent to Audio Record the Interview 
I have read the project information sheet, and I understand that it is my decision whether or not 
the interview is audio-recorded. My decision will not affect in any way how the interviewer treats 
me if I do not want the interview to be audio-recorded.  
I understand that if the interview is audio-recorded that the audio will be destroyed two years after 
the interview.  
I understand that I can ask the person interviewing me to stop audio recording, and to stop the 
interview altogether, at any time.  
I understand that the information that I give will be treated confidentially and that my name will 
not be used when the interviews are typed up. 
 
                  Yes, I give my permission for the interview to be audio recorded. 
                   
                    No, I do not give my permission for the interview to be audio recorded. 
        
Signature ….................................................... 
 
Date …………………………………………. 
 
 
 
 
 
 
 
 
 
